By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cardurion Pharmaceuticals 

64 Sydney Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Cardurion is a recently launched, Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takeda’s strategy to leverage external innovation by placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion.

Cardurion is led by two distinguished physician-scientists with extensive experience in cardiovascular science, medicine and drug development: Daniel Bloomfield, M.D. chief executive officer and Michael Mendelsohn, M.D. founder and executive board chairman.

YEAR FOUNDED:

July 2017

LEADERSHIP:

Founder & Chairman: Michael E. Mendelsohn, M.D.

CEO: Daniel M. Bloomfield, M.D.


Key Statistics


Email: info@cardurion.com
Ownership: Subsidiary

Web Site: Cardurion Pharma
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->